Industry Research Reports

Home > Reports > Service & Software > Global Sepsis Therapeutics Market Research Report 2026

Global Sepsis Therapeutics Market Research Report 2026

Industry: Service & Software

Published Date: 2026-04-28

Pages: 107 Pages

Report ld: 6684139

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Sepsis Therapeutics Market Size(US$)

CAGR 2026-2032

6.7%

Market Size,2032

USD 6,352

Million

Market Snapshot

Market Size in 2026 (Value)

US$ 4,305 million

Market Forecast in 2032(Value)

US$ 6,352 million

CAGR

6.7%

Years Considered

2021-2032

Base Year

2026

Forecast Period

2026-2032

Source: Secondary research, interviews with experts, and QYResearch analysis

The global Sepsis Therapeutics market was valued at US$ 4060 million in 2025 and is anticipated to reach US$ 6352 million by 2032, at a CAGR of 6.7% from 2026 to 2032.

Sepsis is usually treated with intravenous fluids and antibiotics. Typically, antibiotics are given as soon as possible. Often, ongoing care is performed in an intensive care unit. If fluid replacement is not enough to maintain blood pressure, medications that raise blood pressure may be used. Mechanical ventilation and dialysis may be needed to support the function of the lungs and kidneys, respectively. To guide treatment, a central venous catheter and an arterial catheter may be placed for access to the bloodstream. Other measurements such as cardiac output and superior vena cava oxygen saturation may be used. People with sepsis need preventive measures for deep vein thrombosis, stress ulcers and pressure ulcers, unless other conditions prevent such interventions. Some might benefit from tight control of blood sugar levels with insulin. The use of corticosteroids is controversial, with some reviews finding benefit, and others not.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report delivers a comprehensive overview of the global Sepsis Therapeutics market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Sepsis Therapeutics. The Sepsis Therapeutics market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Sepsis Therapeutics market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Sepsis Therapeutics manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

MARKET SEGMENTATION

By Company

Agennix
AstraZeneca
Atox Bio
CytoGenix
Eli Lilly
Endacea
NexBio
Medinox

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Aminoglycosides
Colony Stimulating Factors
Second Generation Cephalosporins
Third Generation Cephalosporins
Glycopeptide Antibiotics
Inhaled Intifectives
Others

Segment by Application

Hospitals
Clinics
Other

biaoTi CHAPTER OUTLINE

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.

Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.

Chapter 3: Provides a detailed view of the competitive landscape for Sepsis Therapeutics companies, covering revenue share, development plans, and mergers and acquisitions.

Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.

Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.

Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.

Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.

Chapter 12: Key findings and conclusions of the report.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Sepsis Therapeutics Market Size Growth Rate by Type: 2021 vs 2025 vs 2032

1.2.2 Aminoglycosides

1.2.3 Colony Stimulating Factors

1.2.4 Second Generation Cephalosporins

1.2.5 Third Generation Cephalosporins

1.2.6 Glycopeptide Antibiotics

1.2.7 Inhaled Intifectives

1.2.8 Others

1.3 Market by Application

1.3.1 Global Sepsis Therapeutics Market Growth by Application: 2021 vs 2025 vs 2032

1.3.2 Hospitals

1.3.3 Clinics

1.3.4 Other

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Sepsis Therapeutics Market Perspective (2021–2032)

2.2 Global Sepsis Therapeutics Growth Trends by Region

2.2.1 Global Sepsis Therapeutics Market Size by Region: 2021 vs 2025 vs 2032

2.2.2 Sepsis Therapeutics Historic Market Size by Region (2021–2026)

2.2.3 Sepsis Therapeutics Forecasted Market Size by Region (2027–2032)

2.3 Sepsis Therapeutics Market Dynamics

2.3.1 Sepsis Therapeutics Industry Trends

2.3.2 Sepsis Therapeutics Market Drivers

2.3.3 Sepsis Therapeutics Market Challenges

2.3.4 Sepsis Therapeutics Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Sepsis Therapeutics Players by Revenue

3.1.1 Global Top Sepsis Therapeutics Players by Revenue (2021–2026)

3.1.2 Global Sepsis Therapeutics Revenue Market Share by Players (2021–2026)

3.2 Global Top Sepsis Therapeutics Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

3.3 Global Key Players Ranking by Sepsis Therapeutics Revenue

3.4 Global Sepsis Therapeutics Market Concentration Ratio

3.4.1 Global Sepsis Therapeutics Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Sepsis Therapeutics Revenue in 2025

3.5 Global Key Players of Sepsis Therapeutics Head Offices and Areas Served

3.6 Global Key Players of Sepsis Therapeutics, Products and Applications

3.7 Global Key Players of Sepsis Therapeutics, Date of General Availability (GA)

3.8 Mergers and Acquisitions, Expansion Plans

4 Sepsis Therapeutics Breakdown Data by Type

4.1 Global Sepsis Therapeutics Historic Market Size by Type (2021–2026)

4.2 Global Sepsis Therapeutics Forecasted Market Size by Type (2027–2032)

5 Sepsis Therapeutics Breakdown Data by Application

5.1 Global Sepsis Therapeutics Historic Market Size by Application (2021–2026)

5.2 Global Sepsis Therapeutics Forecasted Market Size by Application (2027–2032)

6 North America

6.1 North America Sepsis Therapeutics Market Size (2021–2032)

6.2 North America Sepsis Therapeutics Market Growth Rate by Country: 2021 vs 2025 vs 2032

6.3 North America Sepsis Therapeutics Market Size by Country (2021–2026)

6.4 North America Sepsis Therapeutics Market Size by Country (2027–2032)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Sepsis Therapeutics Market Size (2021–2032)

7.2 Europe Sepsis Therapeutics Market Growth Rate by Country: 2021 vs 2025 vs 2032

7.3 Europe Sepsis Therapeutics Market Size by Country (2021–2026)

7.4 Europe Sepsis Therapeutics Market Size by Country (2027–2032)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Ireland

8 Asia-Pacific

8.1 Asia-Pacific Sepsis Therapeutics Market Size (2021–2032)

8.2 Asia-Pacific Sepsis Therapeutics Market Growth Rate by Region: 2021 vs 2025 vs 2032

8.3 Asia-Pacific Sepsis Therapeutics Market Size by Region (2021–2026)

8.4 Asia-Pacific Sepsis Therapeutics Market Size by Region (2027–2032)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia & New Zealand

9 Latin America

9.1 Latin America Sepsis Therapeutics Market Size (2021–2032)

9.2 Latin America Sepsis Therapeutics Market Growth Rate by Country: 2021 vs 2025 vs 2032

9.3 Latin America Sepsis Therapeutics Market Size by Country (2021–2026)

9.4 Latin America Sepsis Therapeutics Market Size by Country (2027–2032)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Sepsis Therapeutics Market Size (2021–2032)

10.2 Middle East & Africa Sepsis Therapeutics Market Growth Rate by Country: 2021 vs 2025 vs 2032

10.3 Middle East & Africa Sepsis Therapeutics Market Size by Country (2021–2026)

10.4 Middle East & Africa Sepsis Therapeutics Market Size by Country (2027–2032)

10.5 Israel

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Agennix

11.1.1 Agennix Company Details

11.1.2 Agennix Business Overview

11.1.3 Agennix Sepsis Therapeutics Introduction

11.1.4 Agennix Revenue in Sepsis Therapeutics Business (2021–2026)

11.1.5 Agennix Recent Development

11.2 AstraZeneca

11.2.1 AstraZeneca Company Details

11.2.2 AstraZeneca Business Overview

11.2.3 AstraZeneca Sepsis Therapeutics Introduction

11.2.4 AstraZeneca Revenue in Sepsis Therapeutics Business (2021–2026)

11.2.5 AstraZeneca Recent Development

11.3 Atox Bio

11.3.1 Atox Bio Company Details

11.3.2 Atox Bio Business Overview

11.3.3 Atox Bio Sepsis Therapeutics Introduction

11.3.4 Atox Bio Revenue in Sepsis Therapeutics Business (2021–2026)

11.3.5 Atox Bio Recent Development

11.4 CytoGenix

11.4.1 CytoGenix Company Details

11.4.2 CytoGenix Business Overview

11.4.3 CytoGenix Sepsis Therapeutics Introduction

11.4.4 CytoGenix Revenue in Sepsis Therapeutics Business (2021–2026)

11.4.5 CytoGenix Recent Development

11.5 Eli Lilly

11.5.1 Eli Lilly Company Details

11.5.2 Eli Lilly Business Overview

11.5.3 Eli Lilly Sepsis Therapeutics Introduction

11.5.4 Eli Lilly Revenue in Sepsis Therapeutics Business (2021–2026)

11.5.5 Eli Lilly Recent Development

11.6 Endacea

11.6.1 Endacea Company Details

11.6.2 Endacea Business Overview

11.6.3 Endacea Sepsis Therapeutics Introduction

11.6.4 Endacea Revenue in Sepsis Therapeutics Business (2021–2026)

11.6.5 Endacea Recent Development

11.7 NexBio

11.7.1 NexBio Company Details

11.7.2 NexBio Business Overview

11.7.3 NexBio Sepsis Therapeutics Introduction

11.7.4 NexBio Revenue in Sepsis Therapeutics Business (2021–2026)

11.7.5 NexBio Recent Development

11.8 Medinox

11.8.1 Medinox Company Details

11.8.2 Medinox Business Overview

11.8.3 Medinox Sepsis Therapeutics Introduction

11.8.4 Medinox Revenue in Sepsis Therapeutics Business (2021–2026)

11.8.5 Medinox Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Global Sepsis Therapeutics Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032

Table 2. Key Players of Aminoglycosides

Table 3. Key Players of Colony Stimulating Factors

Table 4. Key Players of Second Generation Cephalosporins

Table 5. Key Players of Third Generation Cephalosporins

Table 6. Key Players of Glycopeptide Antibiotics

Table 7. Key Players of Inhaled Intifectives

Table 8. Key Players of Others

Table 9. Global Sepsis Therapeutics Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032

Table 10. Global Sepsis Therapeutics Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 11. Global Sepsis Therapeutics Market Size by Region (US$ Million), 2021–2026

Table 12. Global Sepsis Therapeutics Market Share by Region (2021–2026)

Table 13. Global Sepsis Therapeutics Forecasted Market Size by Region (US$ Million), 2027–2032

Table 14. Global Sepsis Therapeutics Market Share by Region (2027–2032)

Table 15. Sepsis Therapeutics Market Trends

Table 16. Sepsis Therapeutics Market Drivers

Table 17. Sepsis Therapeutics Market Challenges

Table 18. Sepsis Therapeutics Market Restraints

Table 19. Global Sepsis Therapeutics Revenue by Players (US$ Million), 2021–2026

Table 20. Global Sepsis Therapeutics Market Share by Players (2021–2026)

Table 21. Global Top Sepsis Therapeutics Players by Tier (Tier 1, Tier 2, and Tier 3), based on Sepsis Therapeutics Revenue, 2025

Table 22. Ranking of Global Top Sepsis Therapeutics Companies by Revenue (US$ Million) in 2025

Table 23. Global 5 Largest Players Market Share by Sepsis Therapeutics Revenue (CR5 and HHI), 2021–2026

Table 24. Global Key Players of Sepsis Therapeutics, Headquarters and Area Served

Table 25. Global Key Players of Sepsis Therapeutics, Products and Applications

Table 26. Global Key Players of Sepsis Therapeutics, Date of General Availability (GA)

Table 27. Mergers and Acquisitions, Expansion Plans

Table 28. Global Sepsis Therapeutics Market Size by Type (US$ Million), 2021–2026

Table 29. Global Sepsis Therapeutics Revenue Market Share by Type (2021–2026)

Table 30. Global Sepsis Therapeutics Forecasted Market Size by Type (US$ Million), 2027–2032

Table 31. Global Sepsis Therapeutics Revenue Market Share by Type (2027–2032)

Table 32. Global Sepsis Therapeutics Market Size by Application (US$ Million), 2021–2026

Table 33. Global Sepsis Therapeutics Revenue Market Share by Application (2021–2026)

Table 34. Global Sepsis Therapeutics Forecasted Market Size by Application (US$ Million), 2027–2032

Table 35. Global Sepsis Therapeutics Revenue Market Share by Application (2027–2032)

Table 36. North America Sepsis Therapeutics Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 37. North America Sepsis Therapeutics Market Size by Country (US$ Million), 2021–2026

Table 38. North America Sepsis Therapeutics Market Size by Country (US$ Million), 2027–2032

Table 39. Europe Sepsis Therapeutics Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 40. Europe Sepsis Therapeutics Market Size by Country (US$ Million), 2021–2026

Table 41. Europe Sepsis Therapeutics Market Size by Country (US$ Million), 2027–2032

Table 42. Asia-Pacific Sepsis Therapeutics Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032

Table 43. Asia-Pacific Sepsis Therapeutics Market Size by Region (US$ Million), 2021–2026

Table 44. Asia-Pacific Sepsis Therapeutics Market Size by Region (US$ Million), 2027–2032

Table 45. Latin America Sepsis Therapeutics Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 46. Latin America Sepsis Therapeutics Market Size by Country (US$ Million), 2021–2026

Table 47. Latin America Sepsis Therapeutics Market Size by Country (US$ Million), 2027–2032

Table 48. Middle East & Africa Sepsis Therapeutics Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 49. Middle East & Africa Sepsis Therapeutics Market Size by Country (US$ Million), 2021–2026

Table 50. Middle East & Africa Sepsis Therapeutics Market Size by Country (US$ Million), 2027–2032

Table 51. Agennix Company Details

Table 52. Agennix Business Overview

Table 53. Agennix Sepsis Therapeutics Product

Table 54. Agennix Revenue in Sepsis Therapeutics Business (US$ Million), 2021–2026

Table 55. Agennix Recent Development

Table 56. AstraZeneca Company Details

Table 57. AstraZeneca Business Overview

Table 58. AstraZeneca Sepsis Therapeutics Product

Table 59. AstraZeneca Revenue in Sepsis Therapeutics Business (US$ Million), 2021–2026

Table 60. AstraZeneca Recent Development

Table 61. Atox Bio Company Details

Table 62. Atox Bio Business Overview

Table 63. Atox Bio Sepsis Therapeutics Product

Table 64. Atox Bio Revenue in Sepsis Therapeutics Business (US$ Million), 2021–2026

Table 65. Atox Bio Recent Development

Table 66. CytoGenix Company Details

Table 67. CytoGenix Business Overview

Table 68. CytoGenix Sepsis Therapeutics Product

Table 69. CytoGenix Revenue in Sepsis Therapeutics Business (US$ Million), 2021–2026

Table 70. CytoGenix Recent Development

Table 71. Eli Lilly Company Details

Table 72. Eli Lilly Business Overview

Table 73. Eli Lilly Sepsis Therapeutics Product

Table 74. Eli Lilly Revenue in Sepsis Therapeutics Business (US$ Million), 2021–2026

Table 75. Eli Lilly Recent Development

Table 76. Endacea Company Details

Table 77. Endacea Business Overview

Table 78. Endacea Sepsis Therapeutics Product

Table 79. Endacea Revenue in Sepsis Therapeutics Business (US$ Million), 2021–2026

Table 80. Endacea Recent Development

Table 81. NexBio Company Details

Table 82. NexBio Business Overview

Table 83. NexBio Sepsis Therapeutics Product

Table 84. NexBio Revenue in Sepsis Therapeutics Business (US$ Million), 2021–2026

Table 85. NexBio Recent Development

Table 86. Medinox Company Details

Table 87. Medinox Business Overview

Table 88. Medinox Sepsis Therapeutics Product

Table 89. Medinox Revenue in Sepsis Therapeutics Business (US$ Million), 2021–2026

Table 90. Medinox Recent Development

Table 91. Research Programs/Design for This Report

Table 92. Key Data Information from Secondary Sources

Table 93. Key Data Information from Primary Sources

Table 94. Authors List of This Report

List of Figures

Figure 1. Sepsis Therapeutics Picture

Figure 2. Global Sepsis Therapeutics Market Size Comparison by Type (US$ Million), 2021–2032

Figure 3. Global Sepsis Therapeutics Market Share by Type: 2025 vs 2032

Figure 4. Aminoglycosides Features

Figure 5. Colony Stimulating Factors Features

Figure 6. Second Generation Cephalosporins Features

Figure 7. Third Generation Cephalosporins Features

Figure 8. Glycopeptide Antibiotics Features

Figure 9. Inhaled Intifectives Features

Figure 10. Others Features

Figure 11. Global Sepsis Therapeutics Market Size by Application (US$ Million), 2021–2032

Figure 12. Global Sepsis Therapeutics Market Share by Application: 2025 vs 2032

Figure 13. Hospitals Case Studies

Figure 14. Clinics Case Studies

Figure 15. Other Case Studies

Figure 16. Sepsis Therapeutics Report Years Considered

Figure 17. Global Sepsis Therapeutics Market Size (US$ Million), Year-over-Year: 2021–2032

Figure 18. Global Sepsis Therapeutics Market Size, (US$ Million), 2021 vs 2025 vs 2032

Figure 19. Global Sepsis Therapeutics Market Share by Region: 2025 vs 2032

Figure 20. Global Sepsis Therapeutics Market Share by Players in 2025

Figure 21. Global Sepsis Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 22. The Top 10 and 5 Players Market Share by Sepsis Therapeutics Revenue in 2025

Figure 23. North America Sepsis Therapeutics Market Size YoY Growth (US$ Million), 2021–2032

Figure 24. North America Sepsis Therapeutics Market Share by Country (2021–2032)

Figure 25. United States Sepsis Therapeutics Market Size YoY Growth (US$ Million), 2021–2032

Figure 26. Canada Sepsis Therapeutics Market Size YoY Growth (US$ Million), 2021–2032

Figure 27. Europe Sepsis Therapeutics Market Size YoY Growth (US$ Million), 2021–2032

Figure 28. Europe Sepsis Therapeutics Market Share by Country (2021–2032)

Figure 29. Germany Sepsis Therapeutics Market Size YoY Growth (US$ Million), 2021–2032

Figure 30. France Sepsis Therapeutics Market Size YoY Growth (US$ Million), 2021–2032

Figure 31. U.K. Sepsis Therapeutics Market Size YoY Growth (US$ Million), 2021–2032

Figure 32. Italy Sepsis Therapeutics Market Size YoY Growth (US$ Million), 2021–2032

Figure 33. Russia Sepsis Therapeutics Market Size YoY Growth (US$ Million), 2021–2032

Figure 34. Ireland Sepsis Therapeutics Market Size YoY Growth (US$ Million), 2021–2032

Figure 35. Asia-Pacific Sepsis Therapeutics Market Size YoY Growth (US$ Million), 2021–2032

Figure 36. Asia-Pacific Sepsis Therapeutics Market Share by Region (2021–2032)

Figure 37. China Sepsis Therapeutics Market Size YoY Growth (US$ Million), 2021–2032

Figure 38. Japan Sepsis Therapeutics Market Size YoY Growth (US$ Million), 2021–2032

Figure 39. South Korea Sepsis Therapeutics Market Size YoY Growth (US$ Million), 2021–2032

Figure 40. Southeast Asia Sepsis Therapeutics Market Size YoY Growth (US$ Million), 2021–2032

Figure 41. India Sepsis Therapeutics Market Size YoY Growth (US$ Million), 2021–2032

Figure 42. Australia & New Zealand Sepsis Therapeutics Market Size YoY Growth (US$ Million), 2021–2032

Figure 43. Latin America Sepsis Therapeutics Market Size YoY Growth (US$ Million), 2021–2032

Figure 44. Latin America Sepsis Therapeutics Market Share by Country (2021–2032)

Figure 45. Mexico Sepsis Therapeutics Market Size YoY Growth (US$ Million), 2021–2032

Figure 46. Brazil Sepsis Therapeutics Market Size YoY Growth (US$ Million), 2021–2032

Figure 47. Middle East & Africa Sepsis Therapeutics Market Size YoY Growth (US$ Million), 2021–2032

Figure 48. Middle East & Africa Sepsis Therapeutics Market Share by Country (2021–2032)

Figure 49. Israel Sepsis Therapeutics Market Size YoY Growth (US$ Million), 2021–2032

Figure 50. Saudi Arabia Sepsis Therapeutics Market Size YoY Growth (US$ Million), 2021–2032

Figure 51. UAE Sepsis Therapeutics Market Size YoY Growth (US$ Million), 2021–2032

Figure 52. Agennix Revenue Growth Rate in Sepsis Therapeutics Business (2021–2026)

Figure 53. AstraZeneca Revenue Growth Rate in Sepsis Therapeutics Business (2021–2026)

Figure 54. Atox Bio Revenue Growth Rate in Sepsis Therapeutics Business (2021–2026)

Figure 55. CytoGenix Revenue Growth Rate in Sepsis Therapeutics Business (2021–2026)

Figure 56. Eli Lilly Revenue Growth Rate in Sepsis Therapeutics Business (2021–2026)

Figure 57. Endacea Revenue Growth Rate in Sepsis Therapeutics Business (2021–2026)

Figure 58. NexBio Revenue Growth Rate in Sepsis Therapeutics Business (2021–2026)

Figure 59. Medinox Revenue Growth Rate in Sepsis Therapeutics Business (2021–2026)

Figure 60. Bottom-up and Top-down Approaches for This Report

Figure 61. Data Triangulation

Figure 62. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

What is the annual compound growth rate of the global Sepsis Therapeutics market size from 2026 to 2032? zhanKai

The annual compound growth rate of the global Sepsis Therapeutics market is 6.7% 2026 to 2032.

What was the global market size of Sepsis Therapeutics in 2026? shouQi

Which region is expected to have the highest market share? shouQi

Which companies rank high in the global Sepsis Therapeutics market? shouQi

What was the global market size of Sepsis Therapeutics in 2032? shouQi

Related Reports

Sepsis Therapeutics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Sepsis Therapeutics was estimated to be worth US$ 4060 million in 2025 and is projected to reach US$ 6352 million, growing at a CAGR of 6.7% from 2026 to 2032.
Published Date: 2026-07-15
Pages: 103
USD 3950.00
(Single User License)
Global Sepsis Therapeutics Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Sepsis Therapeutics market size was US$ 3829 million in 2024 and is forecast to a readjusted size of US$ 5991 million by 2031 with a CAGR of 6.7% during the forecast period 2025-2031.
Published Date: 2025-09-06
Pages: 77
USD 4250.00
(Single User License)
Global Sepsis Therapeutics Market Research Report 2025
The global market for Sepsis Therapeutics was valued at US$ 3829 million in the year 2024 and is projected to reach a revised size of US$ 5991 million by 2031, growing at a CAGR of 6.7% during the forecast period.
Published Date: 2025-02-27
Pages: 72
USD 2900.00
(Single User License)
Sepsis Therapeutics- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Sepsis Therapeutics was estimated to be worth US$ 3829 million in 2024 and is forecast to a readjusted size of US$ 5991 million by 2031 with a CAGR of 6.7% during the forecast period 2025-2031.
Published Date: 2025-02-27
Pages: 87
USD 3950.00
(Single User License)
Global Sepsis Therapeutics Market Insights, Forecast to 2030
Sepsis is usually treated with intravenous fluids and antibiotics. Typically, antibiotics are given as soon as possible. Often, ongoing care is performed in an intensive care unit. If fluid replacement is not enough to maintain blood pressure, medications that raise blood pressure may be used. Mechanical ventilation and dialysis may be needed to support the function of the lungs and kidneys, respectively. To guide treatment, a central venous catheter and an arterial catheter may be placed for access to the bloodstream. Other measurements such as cardiac output and superior vena cava oxygen saturation may be used. People with sepsis need preventive measures for deep vein thrombosis, stress ulcers and pressure ulcers, unless other conditions prevent such interventions. Some might benefit from tight control of blood sugar levels with insulin. The use of corticosteroids is controversial, with some reviews finding benefit, and others not.
Published Date: 2024-04-25
Pages: 93
USD 4900.00
(Single User License)
Sepsis Therapeutics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sepsis is usually treated with intravenous fluids and antibiotics. Typically, antibiotics are given as soon as possible. Often, ongoing care is performed in an intensive care unit. If fluid replacement is not enough to maintain blood pressure, medications that raise blood pressure may be used. Mechanical ventilation and dialysis may be needed to support the function of the lungs and kidneys, respectively. To guide treatment, a central venous catheter and an arterial catheter may be placed for access to the bloodstream. Other measurements such as cardiac output and superior vena cava oxygen saturation may be used. People with sepsis need preventive measures for deep vein thrombosis, stress ulcers and pressure ulcers, unless other conditions prevent such interventions. Some might benefit from tight control of blood sugar levels with insulin. The use of corticosteroids is controversial, with some reviews finding benefit, and others not.
Published Date: 2024-01-24
Pages: 80
USD 3950.00
(Single User License)
Global Sepsis Therapeutics Market Research Report 2024
Sepsis is usually treated with intravenous fluids and antibiotics. Typically, antibiotics are given as soon as possible. Often, ongoing care is performed in an intensive care unit. If fluid replacement is not enough to maintain blood pressure, medications that raise blood pressure may be used. Mechanical ventilation and dialysis may be needed to support the function of the lungs and kidneys, respectively. To guide treatment, a central venous catheter and an arterial catheter may be placed for access to the bloodstream. Other measurements such as cardiac output and superior vena cava oxygen saturation may be used. People with sepsis need preventive measures for deep vein thrombosis, stress ulcers and pressure ulcers, unless other conditions prevent such interventions. Some might benefit from tight control of blood sugar levels with insulin. The use of corticosteroids is controversial, with some reviews finding benefit, and others not.
Published Date: 2024-01-11
Pages: 79
USD 2900.00
(Single User License)

Sepsis Therapeutics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Sepsis Therapeutics was estimated to be worth US$ 4060 million in 2025 and is projected to reach US$ 6352 million, growing at a CAGR of 6.7% from 2026 to 2032.
Published: 2026-07-15
Pages: 103
USD 3950.00 (Single User License)
Global Sepsis Therapeutics Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Sepsis Therapeutics market size was US$ 3829 million in 2024 and is forecast to a readjusted size of US$ 5991 million by 2031 with a CAGR of 6.7% during the forecast period 2025-2031.
Published: 2025-09-06
Pages: 77
USD 4250.00 (Single User License)
Global Sepsis Therapeutics Market Research Report 2025
The global market for Sepsis Therapeutics was valued at US$ 3829 million in the year 2024 and is projected to reach a revised size of US$ 5991 million by 2031, growing at a CAGR of 6.7% during the forecast period.
Published: 2025-02-27
Pages: 72
USD 2900.00 (Single User License)
Sepsis Therapeutics- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Sepsis Therapeutics was estimated to be worth US$ 3829 million in 2024 and is forecast to a readjusted size of US$ 5991 million by 2031 with a CAGR of 6.7% during the forecast period 2025-2031.
Published: 2025-02-27
Pages: 87
USD 3950.00 (Single User License)
Global Sepsis Therapeutics Market Insights, Forecast to 2030
Sepsis is usually treated with intravenous fluids and antibiotics. Typically, antibiotics are given as soon as possible. Often, ongoing care is performed in an intensive care unit. If fluid replacement is not enough to maintain blood pressure, medications that raise blood pressure may be used. Mechanical ventilation and dialysis may be needed to support the function of the lungs and kidneys, respectively. To guide treatment, a central venous catheter and an arterial catheter may be placed for access to the bloodstream. Other measurements such as cardiac output and superior vena cava oxygen saturation may be used. People with sepsis need preventive measures for deep vein thrombosis, stress ulcers and pressure ulcers, unless other conditions prevent such interventions. Some might benefit from tight control of blood sugar levels with insulin. The use of corticosteroids is controversial, with some reviews finding benefit, and others not.
Published: 2024-04-25
Pages: 93
USD 4900.00 (Single User License)
Sepsis Therapeutics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sepsis is usually treated with intravenous fluids and antibiotics. Typically, antibiotics are given as soon as possible. Often, ongoing care is performed in an intensive care unit. If fluid replacement is not enough to maintain blood pressure, medications that raise blood pressure may be used. Mechanical ventilation and dialysis may be needed to support the function of the lungs and kidneys, respectively. To guide treatment, a central venous catheter and an arterial catheter may be placed for access to the bloodstream. Other measurements such as cardiac output and superior vena cava oxygen saturation may be used. People with sepsis need preventive measures for deep vein thrombosis, stress ulcers and pressure ulcers, unless other conditions prevent such interventions. Some might benefit from tight control of blood sugar levels with insulin. The use of corticosteroids is controversial, with some reviews finding benefit, and others not.
Published: 2024-01-24
Pages: 80
USD 3950.00 (Single User License)
Global Sepsis Therapeutics Market Research Report 2024
Sepsis is usually treated with intravenous fluids and antibiotics. Typically, antibiotics are given as soon as possible. Often, ongoing care is performed in an intensive care unit. If fluid replacement is not enough to maintain blood pressure, medications that raise blood pressure may be used. Mechanical ventilation and dialysis may be needed to support the function of the lungs and kidneys, respectively. To guide treatment, a central venous catheter and an arterial catheter may be placed for access to the bloodstream. Other measurements such as cardiac output and superior vena cava oxygen saturation may be used. People with sepsis need preventive measures for deep vein thrombosis, stress ulcers and pressure ulcers, unless other conditions prevent such interventions. Some might benefit from tight control of blood sugar levels with insulin. The use of corticosteroids is controversial, with some reviews finding benefit, and others not.
Published: 2024-01-11
Pages: 79
USD 2900.00 (Single User License)